Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Brisbane 4006, Australia.
Gut Health, QIMR Berghofer Medical Research Institute, Herston, Brisbane 4006, Australia.
J Crohns Colitis. 2019 Mar 30;13(4):451-461. doi: 10.1093/ecco-jcc/jjy188.
This study aimed to characterize the mucosa-associated microbiota in ileal Crohn's disease [CD] patients and in healthy controls in terms of host genotype and inflammation status.
The mucosa-associated microbiotas of intestinal pinch biopsies from 15 ileal CD patients with mild and moderate disease and from 58 healthy controls were analysed based on 16S ribosomal sequencing to determine microbial profile differences between [1] IL23R, NOD2 and ATG16L1 genotypes in healthy subjects, [2] ileal CD patients and control subjects, and [3] inflamed and non-inflamed mucosal tissue in CD patients.
The protective variant of the IL23R gene [rs11209026] significantly impacted the microbial composition in the ileum of healthy subjects and was associated with an increased abundance of phylotypes within the family Christensenellaceae as well as increases in diversity and richness. Comparative analysis of healthy and non-inflamed CD microbiome samples indicated a notable decrease in the abundance of Faecalibacterium prausnitzii as well as Shannon diversity and richness. Inflamed and non-inflamed ileal samples of CD subjects had high intra-individual stability and inter-individual variability, but no significant alterations in diversity, richness or taxa were identified. Calprotectin correlated positively with the abundance of Proteobacteria and negatively with diversity in the samples from healthy subjects.
The observation of low diversity and low abundance of beneficial bacteria in healthy control subjects carrying the IL23R [rs11209026] wild-type GG genotype indicates that the gut microbiome is influenced by host genetics and is altered prior to disease diagnosis. Faecal calprotectin may be a potential non-invasive screening tool for dysbiosis in subjects without disorders of intestinal inflammation.
本研究旨在从宿主基因型和炎症状态两方面,对回肠克罗恩病(CD)患者和健康对照者的黏膜相关微生物群进行特征分析。
采用 16S 核糖体测序技术,对 15 例轻中度回肠 CD 患者和 58 例健康对照者的肠道钳夹活检黏膜相关微生物群进行分析,以确定[1]健康受试者中 IL23R、NOD2 和 ATG16L1 基因型之间、[2]回肠 CD 患者和健康对照者之间、[3]CD 患者炎症和非炎症黏膜组织之间的微生物谱差异。
IL23R 基因的保护性变异体[rs11209026]显著影响健康受试者回肠的微生物组成,与 Christensenellaceae 家族内的菌属丰度增加以及多样性和丰富度增加相关。健康和非炎症性 CD 微生物组样本的比较分析表明,Faecalibacterium prausnitzii 的丰度以及 Shannon 多样性和丰富度显著降低。CD 受试者的炎症和非炎症回肠样本具有较高的个体内稳定性和个体间变异性,但未发现多样性、丰富度或分类群有显著改变。健康受试者样本中,钙卫蛋白与变形菌门的丰度呈正相关,与多样性呈负相关。
携带 IL23R[rs11209026]野生型 GG 基因型的健康对照者中,观察到多样性低和有益菌丰度低,表明肠道微生物群受宿主遗传影响,并在疾病诊断前发生改变。粪便钙卫蛋白可能是一种用于无肠道炎症紊乱受试者肠道微生态失调的潜在非侵入性筛查工具。